Applications of 4-Bromo-2-Methyl-3-Pyridinamine in Industrial Manufacturing

4-Bromo-2-Methyl-3-Pyridinamine serves as a highly selective building block within specialized chemical synthesis, supporting targeted downstream manufacturing in the pharmaceutical, agrochemical, and specialty chemical sectors. Our manufacturing expertise ensures consistent quality for each application scenario, maximizing reliability in finished-product lines and compliance with rigorous industry standards.

1. Active Pharmaceutical Ingredient (API) Intermediate for Anti-Infective Agents

This pyridine derivative is primarily applied as an advanced intermediate during the synthesis of certain anti-infective pharmaceutical actives, including molecules in the quinoline and pyridine antimicrobial class. Pharmaceutical manufacturers accept this intermediate for its ability to contribute to regioselective substitution and improved synthetic yields, especially in telescoped multi-step reactions aligned with advanced process chemistry requirements for regulated drug substances.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice (GMP) for Active Pharmaceutical Ingredients
• EU Regulation No 536/2014 (Clinical trial supply chain intermediate controls)
• USP–NF Monographs on Intermediates (reference for process-related impurities)
• ISO 9001:2015 Quality Management Systems certification (supply reliability and traceability)

Typical usage ratio

• 0.7–1.1 molar equivalents to target API core structure, adjusted by synthesis scale and impurity control plan

Downstream process integration

• Introduced after initial halogenation step, participates directly in nucleophilic aromatic substitution under controlled temperature and pressure as part of a multi-step synthetic route
• Monitored for residual presence in final drug substance using stage-specific in-process controls

Final product types

• Registered anti-infective active pharmaceutical ingredients (e.g., pyridine-based antibiotics, antimalarial precursors)
• Clinical trial material meeting full cGMP documentation

2. Agrochemical Synthesis for Fungicide Discovery Programs

Major crop protection R&D operations employ this compound as a rigid aromatic amine structural motif for early-stage lead generation within novel fungicide pipelines. Chemical research teams use it to generate diverse libraries, enabling fine-tuned activity mapping in structure–activity relationship (SAR) studies for new active ingredients. The compound’s substitution pattern plays a critical role in modulating target binding in heterocyclic lead optimization.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP) for agrochemical R&D
• REACH Registration, Evaluation, Authorisation and Restriction of Chemicals (for all supplied intermediates)
• ISO 17025 Laboratory Accreditation (analytical method validation in intermediate handling)
• EPA 40 CFR Part 169 (pesticide records and reporting)

Typical usage ratio

• 0.3–0.9 parts by weight per 1 part target heterocycle, adjusted depending on diversification scheme intensity

Downstream process integration

• Incorporated into amination coupling or Buchwald–Hartwig cross-coupling in scale-up or parallel medicinal chemistry workflows
• Used as a platform for combinatorial array generation in research and pilot-scale batch reactors

Final product types

• Candidate seed and foliar fungicide chemistries for field trial registration
• Experimental agrochemical formulation samples for premarket environmental safety testing

3. Dye and Pigment Intermediate for High-Performance Electronics Coatings

Downstream specialty pigment manufacturers rely on this pyridine amine as a nucleophile when developing high-purity dye intermediates, especially for optoelectronic coatings. Its integration supports precise color modulation and electronic property tuning, which is essential in producing organic semiconducting polymers and advanced functional coatings for electronic displays or photovoltaic layers, where consistency of chromatic and electronic properties must adhere to strict industry benchmarks.

Industry compliance standards

• IEC 62471 (Photobiological safety in display and lighting applications)
• RoHS Directive 2011/65/EU (Restriction of Hazardous Substances in electronics coatings)
• ISO 9001:2015 (Process quality assurance for colorant intermediates)
• REACH Annex XVII (Restriction listing for aromatic amines in consumer goods)

Typical usage ratio

• 0.08–0.2 parts by mass within the pigment-forming reaction, with the amount varied according to desired colorant purity or electronic performance specification

Downstream process integration

• Added at the penultimate synthetic stage in pigment production, commonly under condensation or electrophilic substitution conditions to establish chromophore connectivity
• Subjected to rigorous trace impurity removal before pigment isolation and coating formulation

Final product types

• Organic dye precursors for OLED and LCD display coatings
• Functional pigment dispersions for printed circuit board soldermask inks

4. Chemical Research and Custom Synthesis for Next-Generation Heterocycle Libraries

Contract research organizations (CROs) and advanced chemical synthesis firms utilize this raw material to develop new libraries of functionalized pyridines and related heterocycles for patent landscaping and proprietary technology platforms. The material’s characteristic structure allows rapid functional group transformations, supporting customized analog development for leading universities and industrial research parks.

Industry compliance standards

• ISO 13485:2016 (Quality management for chemical intermediates in regulated R&D pipelines)
• 21 CFR Part 211 (cGMP requirements for investigational use intermediates)
• REACH notification for laboratory chemical use
• Local chemical safety and handling registrations (laboratory accreditation boards)

Typical usage ratio

• 0.1–0.5 molar equivalents within multi-component heterocycle synthesis, flexibly altered by library design and scale

Downstream process integration

• Fed into solution-phase or solid-phase parallel synthesis modules, typically following initial amine protection or deprotection steps
• Reacted through electrophilic, cross-coupling, or reductive amination transformations for library generation

Final product types

• Patented heterocyclic scaffolds for pharmaceutical and material science applications
• Reference standard libraries for high-throughput screening and early-stage lead validation